Cowen Starts Celldex Therapeutics (CLDX) at Outperform
Tweet
Share
E-mailGet Alerts CLDX Hot Sheet
Price: $41.70 -0.22%
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 16
Rating Summary:
18 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 9 | New: 16
Join SI Premium – FREE
Cowen initiated coverage on Celldex Therapeutics (NASDAQ: CLDX) with an Outperform rating and a price target of $22.00.
For an analyst ratings summary and ratings history on Celldex Therapeutics click here. For more ratings news on Celldex Therapeutics click here.
Shares of Celldex Therapeutics closed at $14.16 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Hesai (2525:HK) (HSAI) at Buy
- BMO Capital Starts Prime Medicine (PRME) at Outperform
- BMO Capital Starts Perspective Therapeutics Inc (CATX) at Outperform
Create E-mail Alert Related Categories
New CoverageRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
